Teva reports second quarter 2014 results
Teva reported revenues of $5.0 billion in the 2014 second quarter, up 2% compared to the second quarter of 2013. GAAP net income and GAAP diluted EPS were $748 million and $0.87 in the 2014 second quarter versus a loss of $452 million and a loss per share of $0.53 in the same 2013 quarter. July 31, 2014